High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparison.

Sorry, there's nothing here.

Statistics

05001000'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

103 Citations

Semantic Scholar estimates that this publication has 103 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Hiddemann1991HighdoseVI, title={High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparison.}, author={Wolfgang C Hiddemann and Carlo Aul and Georg Maschmeyer and R Sch{\"{o}nrock-Nabulsi and W. D. Ludwig and Andrea Bartholom{\"a}us and Peter Bettelheim and Klaus Becker and Leopold Balleisen and B Lathan}, journal={Seminars in hematology}, year={1991}, volume={28 3 Suppl 4}, pages={35-8} }